Clinical efficacy and safety of 6-thioguanine in the treatment of childhood acute lymphoblastic leukemia: A protocol for systematic review and meta-analysis

BACKGROUND: To systematic review the efficacy and safety of 6-thioguanine (6-TG) in the substitute of 6-mercaptopurine (6-MP) in the treatment for patients with childhood acute lymphoblastic leukemia (ALL) in the maintenance phase, and to explore its clinical application value. It provides theoretic...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang, Yan, Huai-Xiu, Liu, Xiao-Wei, Chen, Wen-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440359/
https://www.ncbi.nlm.nih.gov/pubmed/32358392
http://dx.doi.org/10.1097/MD.0000000000020082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440359/
https://www.ncbi.nlm.nih.gov/pubmed/32358392
http://dx.doi.org/10.1097/MD.0000000000020082

Ejemplares similares